Experimental evidence indicates that hypercalcemia inhibits the binding of antidiuretic hormone (ADH) to its receptor and reduces medullary adenylate cyclase activity, a crucial step in the ADH mechanism. Here, ADCY1 is linked to hypercalcemia disease.